TOXINS 2024 Register Now Banner
Injector Preceptorship Program

A Letter From Our President

Dear Colleague,

Welcome to the International Neurotoxin Association (INA). We are a not-for-profit, international scientific society dedicated to advancing scientific research, supporting education, and fostering understanding about botulinum and other neurotoxins.

The INA provides a forum for the exchange of information and ideas among scientists, clinicians, and other allied health professionals about the science and therapeutic use of neurotoxins.

The key forum for the exchange of information and ideas are the international neurotoxin conferences. The TOXINS 2024 7th International Conference took place 17-20 January, at the Estrel Hotel and Convention Center, in Berlin, Germany.

The conference was a tremendous success with 1207 clinicians and scientists from 59 countries and a US and international faculty of 113. One hundred sixty-two conference abstracts have been published in the journal Toxicon; 135 posters were presented and displayed.

The conference abstracts published in Toxicon are available via open access for 6 months. Abstracts can be accessed by following the link below:

In addition to organizing the biennial TOXINS Conferences, the INA has now initiated the Injector Preceptorship Initiative.

This one-on-one preceptorship program is designed for injectors of all levels of experience—from novice to expert—who wish to learn and/or improve their injection skills using botulinum neurotoxin. Click on the preceptorship link to view the program and mentors.

I wish to invite you to join the INA. Our membership is open to individuals with an interest in the field and can be requested by clicking on the “Membership” tab above and completing the application form. Currently, there is no fee for membership. I look forward to welcoming you as an INA member!

Best regards,

David M. Simpson Signature

David M. Simpson, MD
International Neurotoxin Association

Join Our Mailing List

Click here to sign up, and then manage your subscription.